Clinically, a copy number abnormality was reported in 20% of the patients with ovarian cancer [111] including claudin 4 (CLDN4), RAS oncogene family (RAB25), and ATP binding cassette subfamily F member 2 (ABCF2) [112, 113]. This evidence concerns the gene ABCF2 and ovarian cancer.